However, finding doctors comfortable prescribing compounded GLP-1s proves difficult in many areas, and local compounding pharmacies may not stock tirzepatide or may have limited availability
Dosed and monitored based on your specific biomarkers
Retatrutide dosage In phase 2 clinical trials, retatrutide was given in the following doses: 1mg, 2mg or 4mg (starting dose) 1mg, 4mg, 8mg or 12mg per week (maintenance dose) 12mg per week (maximum dose) The dose escalation was similar to other weight loss medications, with the retatrutide dose increasing every 4 weeks
While considered generally safe when prescribed correctly, improper dosing can cause serious side effects
To date, no existing research has discovered any serious safety concerns with the use of GHK-Cu copper peptides